Jeff Yass’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
Other funds holding AQST
BCM
Jeff Yass's AQST Position: Q3 2026 in Review
Jeff Yass reduced its Aquestive Therapeutics (AQST) stake by 59% in Q3 2026, selling an estimated $334K and leaving 53,256 shares worth $247K. The position accounts for ﹤0.01% of the portfolio, ranked #11444.
Jeff Yass first reported a position in AQST in Q4 2019 and has held it in 25 quarters since. The position peaked at $6.09M in Q3 2025. 188 funds tracked by Wall St. Rank hold AQST as of Q3 2026.
- Jeff Yass held 53,256 shares of Aquestive Therapeutics worth $247K as of Q3 2026.
- Jeff Yass sold 75,249 Aquestive Therapeutics shares in Q3 2026, an estimated $334K.
- Aquestive Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #11444 holding.
- Jeff Yass first reported a position in Aquestive Therapeutics in Q4 2019 and has held it in 25 quarters since.
- Jeff Yass's Aquestive Therapeutics position peaked at $6.09M in Q3 2025.
- 188 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.